first glp 1 approved FDA Approves Oral Semaglutide: GLP-1 Weight Loss Pill History of GLP-1 Medications -

This compound is not FDA approved

Following the launch of Mounjaro in 2022, the number of patients on GLP-1 therapy exploded, with a 200% increase in unique patients in 12 months

Retatrutide is an investigational once-weekly injection developed by Eli Lilly

doi: 10.1136/heartjnl-2024-324170

That matters because weight loss does not necessarily equate to better health, especially if too much of that loss comes from the muscle

Enfermedad biliar (colelitiasis/colecistitis): Un meta-anlisis de 76 ensayos clnicos randomizados muestra RR 1,37 (mayor riesgo a dosis altas , uso prolongado y cuando se usan para prdida de peso